• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝前性门静脉高压症中的血管舒张和钠潴留

Vasodilatation and sodium retention in prehepatic portal hypertension.

作者信息

Albillos A, Colombato L A, Groszmann R J

机构信息

Hepatic Hemodynamic Laboratory, Department of Veterans Affairs, Medical Center, West Haven, Connecticut.

出版信息

Gastroenterology. 1992 Mar;102(3):931-5. doi: 10.1016/0016-5085(92)90179-3.

DOI:10.1016/0016-5085(92)90179-3
PMID:1537529
Abstract

Sodium retention and peripheral vasodilatation are common consequences of portal hypertension secondary to cirrhosis. Although peripheral vasodilatation has been extensively documented in prehepatic portal hypertension, it is not known whether sodium retention is also a feature of this entity. The aim of this study in portal vein-constricted rats was to evaluate (a) whether sodium retention is a feature of prehepatic portal hypertension and (b) if sodium retention is present in this model, what its temporal relationship with peripheral vasodilatation might be. It was proposed that an understanding of the temporal interplay between peripheral vasodilatation and sodium retention could shed light on the current theories of sodium retention in portal hypertension. Rats were studied 1, 2, 3, and 4 days after partial portal vein ligation (n = 80) or sham operation (n = 63). Sodium retention was evaluated by changes in the size of the sodium space measured by the volume of distribution of 22Na. Systemic vascular resistance was calculated from mean arterial pressure (measured by arterial catheterization) and cardiac index (measured by thermodilution). A decrease in systemic vascular resistance was already observed on day 1 after constriction of the portal vein (4.2 +/- 0.2 vs. 5.2 +/- 6.1 mm Hg.min.mL-1.100 g; P less than 0.01). However, an expansion of the sodium space, which indicates sodium retention, was not observed until day 2 after induction of portal hypertension (37.1 +/- 0.8 vs. 32.6 +/- 0.7 mL.100 g-1; P less than 0.01). Therefore, sodium retention should be considered along with peripheral vasodilatation among the characteristic features of prehepatic portal hypertension. Because the reduction in systemic vascular resistance preceded the expansion of the sodium space by at least 24 hours, the finding of this study indicates that sodium retention follows peripheral vasodilatation.

摘要

钠潴留和外周血管扩张是肝硬化继发门静脉高压的常见后果。尽管外周血管扩张在肝前性门静脉高压中已有广泛记载,但尚不清楚钠潴留是否也是该病症的一个特征。本研究旨在评估门静脉缩窄大鼠模型中:(a) 钠潴留是否为肝前性门静脉高压的一个特征;(b) 如果该模型中存在钠潴留,那么它与外周血管扩张的时间关系是怎样的。有人提出,了解外周血管扩张和钠潴留之间的时间相互作用可能有助于阐明当前门静脉高压钠潴留理论。对部分门静脉结扎术后1、2、3和4天的大鼠(n = 80)或假手术大鼠(n = 63)进行研究。通过用22Na分布容积测量钠空间大小的变化来评估钠潴留情况。根据平均动脉压(通过动脉插管测量)和心指数(通过热稀释测量)计算全身血管阻力。门静脉缩窄后第1天即已观察到全身血管阻力降低(4.2±0.2 vs. 5.2±6.1 mmHg·min·mL-1·100 g;P < 0.01)。然而,直到门静脉高压诱导后第2天才观察到表明钠潴留的钠空间扩大(37.1±0.8 vs. 32.6±0.7 mL·100 g-1;P < 0.01)。因此,钠潴留应与外周血管扩张一并被视为肝前性门静脉高压的特征。由于全身血管阻力降低比钠空间扩大至少提前24小时出现,本研究结果表明钠潴留发生在外周血管扩张之后。

相似文献

1
Vasodilatation and sodium retention in prehepatic portal hypertension.肝前性门静脉高压症中的血管舒张和钠潴留
Gastroenterology. 1992 Mar;102(3):931-5. doi: 10.1016/0016-5085(92)90179-3.
2
The role of central blood volume in the development of sodium retention in portal hypertensive rats.中心血容量在门静脉高压大鼠钠潴留形成中的作用。
Gastroenterology. 1996 Jan;110(1):193-8. doi: 10.1053/gast.1996.v110.pm8536856.
3
Octreotide ameliorates vasodilatation and Na+ retention in portal hypertensive rats.
Gastroenterology. 1993 Feb;104(2):575-9. doi: 10.1016/0016-5085(93)90429-g.
4
Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal-hypertensive rats.门静脉高压大鼠外周血管舒张、血浆容量扩张与高动力循环状态的时间关系。
Hepatology. 1992 Feb;15(2):323-8. doi: 10.1002/hep.1840150224.
5
N omega-nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats.给予Nω-硝基-L-精氨酸可纠正门静脉高压大鼠的外周血管舒张和全身毛细血管低血压,并改善血浆容量扩张和钠潴留。
Hepatology. 1993 Jan;17(1):84-90.
6
Reduced liver function is the trigger for renal sodium retention following portal vein ligation in the rat.肝功能减退是大鼠门静脉结扎后肾钠潴留的触发因素。
J Gastroenterol Hepatol. 1996 Sep;11(9):850-6. doi: 10.1111/j.1440-1746.1996.tb00092.x.
7
Hyperdynamic circulation in prehepatic portal hypertension: role of tumor necrosis factor-alpha.肝前性门静脉高压症中的高动力循环:肿瘤坏死因子-α的作用
Zhonghua Yi Xue Za Zhi (Taipei). 1997 Mar;59(3):145-50.
8
Interaction of flow and resistance in maintenance of portal hypertension in a rat model.大鼠模型中血流与阻力在门静脉高压维持中的相互作用
Am J Physiol. 1986 Feb;250(2 Pt 1):G205-12. doi: 10.1152/ajpgi.1986.250.2.G205.
9
Na restriction blunts expansion of plasma volume and ameliorates hyperdynamic circulation in portal hypertension.钠限制可抑制门静脉高压症时血浆容量的扩张并改善高动力循环。
Am J Physiol. 1990 Sep;259(3 Pt 1):G498-503. doi: 10.1152/ajpgi.1990.259.3.G498.
10
[Portal-systemic shunting and hemodynamics of prehepatic portal hypertensive rat models].[肝前性门静脉高压大鼠模型的门体分流与血流动力学]
Zhonghua Wai Ke Za Zhi. 1997 Apr;35(4):244-7.

引用本文的文献

1
Low-dose alcohol exacerbates hyperdynamic circulation and shunting in non-alcoholic cirrhotic rats.低剂量酒精可加重非酒精性肝硬化大鼠高动力循环和分流。
Biosci Rep. 2024 Jul 31;44(7). doi: 10.1042/BSR20240354.
2
Use of machine learning models for the prognostication of liver transplantation: A systematic review.机器学习模型在肝移植预后评估中的应用:一项系统综述。
World J Transplant. 2024 Mar 18;14(1):88891. doi: 10.5500/wjt.v14.i1.88891.
3
Curcumol Attenuates Portal Hypertension and Collateral Shunting Via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats.
莪术醇通过抑制肝硬化大鼠肝外血管生成减轻门静脉高压和侧支分流
Biochem Genet. 2025 Feb;63(1):281-297. doi: 10.1007/s10528-024-10684-x. Epub 2024 Mar 4.
4
Effects of PCSK-9 Inhibition by Alirocumab Treatments on Biliary Cirrhotic Rats.阿利西尤单抗治疗对胆汁性肝硬化大鼠的影响。
Int J Mol Sci. 2022 Jul 2;23(13):7378. doi: 10.3390/ijms23137378.
5
Matrix metalloproteinase-9 inhibition or deletion attenuates portal hypertension in rodents.基质金属蛋白酶-9 抑制或缺失可减轻啮齿动物的门静脉高压。
J Cell Mol Med. 2021 Nov;25(21):10073-10087. doi: 10.1111/jcmm.16940. Epub 2021 Oct 14.
6
Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats.甘草酸通过抑制肝硬化大鼠肝外血管生成减轻门脉高压和侧支分流。
Int J Mol Sci. 2021 Jul 17;22(14):7662. doi: 10.3390/ijms22147662.
7
NAFLD Aggravates Septic Shock Due to Inadequate Adrenal Response and 11β-HSDs Dysregulation in Rats.非酒精性脂肪性肝病因大鼠肾上腺反应不足和11β-羟基类固醇脱氢酶失调而加重脓毒性休克。
Pharmaceutics. 2020 Apr 28;12(5):403. doi: 10.3390/pharmaceutics12050403.
8
Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats.双重血管紧张素受体和中性肽链内切酶抑制剂改善门静脉高压大鼠的门静脉高压
Pharmaceutics. 2020 Apr 2;12(4):320. doi: 10.3390/pharmaceutics12040320.
9
Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats.硫代葡萄糖苷代谢产物可改善胆管结扎大鼠门静脉高压和肝硬化的发展。
Int J Mol Sci. 2019 Aug 26;20(17):4161. doi: 10.3390/ijms20174161.
10
The beneficial effects of curcumin in cirrhotic rats with portal hypertension.姜黄素对肝硬化门静脉高压症大鼠的有益作用。
Biosci Rep. 2017 Dec 15;37(6). doi: 10.1042/BSR20171015. Print 2017 Dec 22.